Cytokines and growth factors are important mediators of progesterone-regulated endometrial receptivity and embryo development. Early luteal phase administration of a potent antiprogestin-like mifepristone to the rhesus monkey results in endometrial desynchrony, loss of embryo viability and implantation failure. In the present study, administration of mifepristone (2 mg/kg body weight, s.c.) on day 2 after ovulation resulted in a significant increase (P < 0.01) in the level of tumor necrosis factor a (TNFa) in glandular and vascular compartments of endometrium, and in endometrial secretion and luminal fluid on day 6 after ovulation in the rhesus monkey. There was an associated lag in embryonic development, characterized by delayed mitochondrial maturity, poorly developed junctional complexes, a relative absence of intra-cytoplasmic filaments and a high degree of intra-cellular degenerative features. Exposure of TNFa (0, 0.5, 5, 50 ng/ml) to preimplantation stage mouse embryos in vitro showed a dose-dependent arrest in growth and development at both morula and blastocyst stages along with ultrastructural features of degeneration similar to those observed in embryos collected from early luteal phase mifepristone-treated monkeys. The de novo synthesized and released proteins in terms of trichloroacetic acid precipitable 35 S by morulae and blastocysts in vitro showed a marked depression following exposure to TNFa compared with control embryos. Based on the above observation and the fact that preimplantation stage embryos express receptors for TNFa, we suggest that increased levels of TNFa in endometrial and luminal compartments around the time of uterine receptivity following early luteal phase administration of mifepristone adversely affect the growth and viability of preimplantation stage embryos.
Introduction
The viability and growth of preimplantation embryos, as well as implantation of blastocysts, are regulated by a complex network of autocrine and paracrine processes involving a large number of factors (Edwards 1995 , Polan et al. 1995 . Progesterone is essential for endometrial preparation for blastocyst implantation . We have demonstrated previously in the rhesus monkey that a potent antiprogestin-like mifepristone inhibits blastocyst implantation (Ghosh & Sengupta 1993) because the endometrium becomes desynchronized following early luteal phase mifepristone treatment in this species (Ghosh et al. 1996 . We have also demonstrated that early luteal phase exposure to mifepristone inhibits the morula-to-blastocyst transition as well as the viability of blastocysts in the rhesus monkey (Ghosh et al. 1997 . We hypothesize that inhibition of progesterone action in the endometrium alters the profiles of cytokines in endometrium and luminal milieu that in turn affects embryonic growth and viability during the preimplantation stage of gestation. Among the various principal cytokines which may reportedly be involved in these processes, tumor necrosis factor a (TNFa) appears to be a strong candidate . Progesterone inhibits TNFa synthesis and secretion in endometrium (von Wolff et al. 1999 ). TNFa appears to be inhibitory to the viability, growth and differentiation of preimplantation stage blastocysts (Hill et al. 1987 , Pampfer et al. 1994a ,b, Wuu et al. 1999 , Ben-yair et al. 1997 , Kurzawa et al. 2001 . However, human embryos secrete TNFa in vitro until morula stage, but not at blastocyst stage (Lachapelle et al. 1993) . Thus, it is not known whether TNFa can specifically influence morulato-blastocyst transition and blastocyst differentiation. In the present study, we have examined this question by investigating: (i) the levels of synthesis and secretion of TNFa by implantation stage endometrium, as well as the morphological characteristics of preimplantation stage embryos following early luteal phase mifepristone treatment to rhesus monkeys, and (ii) the effect of TNFa on the functional and developmental characteristics of mouse morulae and blastocysts following their in vitro exposure to TNFa. Mouse embryos were used in the second part of the study because of the ethical and practical constraints in the use of monkey embryos. Our results lend support to the proposed hypothesis that endometrial and luminal levels of TNFa increase around the time of uterine receptivity following early luteal phase mifepristone action in the rhesus monkey and that TNFa adversely affects the growth and viability of preimplantation stage embryos.
Materials and Methods

Experiments using monkeys
General procedures and treatment groups
Healthy, mature and proven fertile male and female rhesus monkeys (Macaca mulatta) that were kept in a semi-natural condition at the Primate Research Facility of the All India Institute of Medical Sciences (New Delhi, India) were used in this study. The details of animal selection, housing, management, monitoring of cycles, mating, laparotomy, endometrial sampling, serum collection and radioimmunoassay for serum estradiol-17b and progesterone have been described elsewhere (Ghosh & Sengupta 1993 , Ghosh et al. 1996 , Ghosh et al. 1997 . The study design was approved by the Ethics Committee for the Use of Van-human Primates in Biomedical Research of the All India Institute of Medical Sciences.
Female monkeys showing at least two consecutive ovulatory menstrual cycles of normal length (26 -32 days) were allocated to two groups. Animals (n ¼ 25) were allowed to cohabit with males during days 8-16 of their menstrual cycles. Vaginal smears were checked daily for the presence of spermatozoa. Female monkeys of group 1 were injected s.c. with 2 ml vehicle (1:4, benzyl benzoate:olive oil, v/v; n ¼ 10) only and animals of group 2 were injected s.c. a single dose of mifepristone (2 mg/kg body weight; n ¼ 15) in the same volume of vehicle on day 2 after ovulation in mated cycles. In groups 1 and 2, endometrial samples were collected on day 6 after ovulation and samples only from mated, ovulatory cycles that yielded preimplantation stage embryos were used for further examination in this study. Recovered embryos were assessed for their developmental status under stereo-zoom microscope as described earlier . After retrieval of the embryo, the uterine fluid was kept at 270 8C for subsequent estimation of TNFa concentration by enzyme immunoassay as described below. Table 1 shows the details of the embryos recovered from both groups on day 6 after ovulation. The days of ovulation in both groups were assessed from the profiles of estradiol-17b and progesterone in peripheral serum samples. Steroid radioimmunoassays were performed using antisera and reagents obtained from the World Health Organization Matched Reagent Programme. The methodological details are described elsewhere (Ghosh & Sengupta 1993 , Ghosh et al. 1996 , Ghosh et al. 1997 .
Tissue collection and processing
The procedural details of collection and processing of endometrial samples for Western immunoblotting and immunohistochemistry have been described elsewhere (Ghosh et al. 1996 . Briefly, endometrial samples were collected on day 6 after ovulation from animals of group 1 (n ¼ 6) and group 2 (n ¼ 7) by performing laparotomy and fundal hysterotomy following ketamine (12 mg/kg; Vetlar, Parke-Davis, Mumbai, India) anaesthesia. For immunohistochemistry, the tissue samples were quickly washed in ice-cold phosphate buffered saline and then fixed in phosphate buffered neutral paraformaldehyde (4%, w/v) and finally embedded in paraffin wax by a routine procedure. Furthermore, tissue samples were also homogenized in TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0) with 1 mM phenyl methyl sulphonyl fluoride (PMSF). Additionally, tissue samples were also processed for incubation in phenol red free Eagle's minimum essential medium for 16 h at 37 8C in a humidified environment of 5% carbon dioxide and 95% air. Tissue homogenates and spent media were used for dot blot and western blot analysis. All chemicals were purchased from Sigma Chemical Co. (St. Louis MO, USA).
Immunoblot, enzyme immunoassay and immunohistochemistry
Profiles of TNFa in tissue spent media were characterized by the SDS-PAGE/western immunoblotting method as described elsewhere ) using electrophoresis and trans-blot equipment from Bio-Rad (Hercules CA, USA), and the materials and chemicals Endometrial tissue homogenate (10 mg of protein) was also taken for dot blot study using nitrocellulose membrane. The blocking of the nonspecific binding, immunoliganding with antibody (R&D Systems) against TNFa and final visualization was achieved using protocol as described above. Respective primary antibody control and secondary antibody control were run to examine the specificity of the procedure. Semi-quantitative estimates of integral optical density were recorded.
The concentrations of TNFa in uterine fluid collected from animals of group 1 (n ¼ 6) and group 2 (n ¼ 7) yielding embryos were determined by enzyme immunoassay using chemicals from R&D Systems according to the protocol provided by the manufacturer and expressed in terms of total protein estimated by Bio-Rad protein assay reagent (Gogstad & Krutness 1982) .
5 mm paraffin sections were employed for immunohistochemical localization of TNFa using specific antibody (R&D Systems) at a working dilution of 7.5 mg/ml. Visualization was achieved using Vectastain ABC Peroxidase Elite Kit (Vector Laboratories, Burlingame, USA) and 3,3 0 -diaminobenzidine hydrochloride (Sigma Chemical Co.) and hydrogen peroxide following a method described previously (Ghosh et al. 1997) . Respective primary antibody control and secondary antibody control were run simultaneously. Semi quantitative analysis of the area of immunoprecipitation for TNFa on the endometrial sections was done using computer aided image analysis (Quantimet C þ , Leica, Germany) as described earlier .
The specificity of the antibody binding in western blot and immunohistochemistry was checked by immunoneutralization using recombinant human TNFa (R&D Systems) as described previously (Ho et al. 1999 ).
Detection of TNF-Receptor I (TNF-RI) in monkey blastocysts
Two blastocyst stage embryos were recovered from mated rhesus monkeys on day 6 after ovulation, as described above, and were fixed in 4% paraformaldehyde in 0.1 mol/l phosphate buffer (pH 7.2) and washed in cold phosphate buffer followed by dehydration in graded alcohol and embedded in London Resin (LR) white (Electron Microscopy Sciences, Fort Washington, PA, USA). Semithin (1 mm) sections were cut and stained with toluidine blue as detailed previously (Ghosh et al. 1996) . Prior to immunohistochemical localization of TNF-R1, the endogenous peroxidase in the embryo sections were quenched with 0.3% hydrogen peroxide following the unmasking of antigens with 0.125% (w/v) trypsin for 10 min. After washing the sections in phosphate buffered saline (pH 7.2), the sections were blocked with 2% (v/v) goat serum and exposed to anti-rabbit polyclonal antibody against hTNF-RI (Santa Cruz biotechnology, Santa Cruz, CA, USA) at 4 8C overnight. Subsequent visualization steps were performed using Vectastain Elite ABC kit and enhancing solution (Vector Laboratories).
Experiments using mice
Mouse embryo collection and culture Random-bred sexually mature Swiss albino female mice were subjected to superovulation and allowed to mate with adult males using standardized protocol (Hogan et al. 1994) . Day 1 of pregnancy was designated from the day of detection of copulatory plug. Uterine horns were flushed with M2 medium (pH 7.4) on the morning of day 4 (Pratt 1987) . Morulae and blastocysts with normal appearance under phase contrast microscope were collected and used in different experiments as described below.
Medium M16 (pH 7.6) supplemented with sodium pyruvate (36 mg w/v), bovine serum albumin (0.4% w/v) along with different concentrations (0, 0.5, 5 and 50 ng/ml) of TNFa (R&D Systems) was used at a ratio of 50 ml/embryo to culture morulae (group I) and blastocysts (group II) taken in randomly assigned pool of four embryos in humidified 5% carbon dioxide in air at 37 8C (Pratt 1987) . Cultures were terminated at 24 h because the half-life of TNFa is about 30 h in culture medium (Wincek et al. 1991) . The study design had been approved by the Institutional Animal Ethics Committee of AIIMS. Tables 2 and 3 show the details of different groups used in this experiment.
Developmental status of cultured mouse embryos
After 24 h culture, embryos were used to examine developmental status under light microscope. Tables 2 and 3 show the number of embryos in group I (morulae) and group II (blastocyst) used and the parameters examined to assess developmental status in this experiment.
Protein synthesis by mouse embryos
In order to examine the protein synthetic ability of morulae (group I) and blastocysts (group II) with or without TNFa (0.5, 5.0, 50.0 ng/ml) in vitro, embryos (,100 embryos per incubation) were cultured for 4 h in M16 medium (as described above) containing 100 mCi/ml of 35 S-methionine (Neider et al. 1987) . Embryos were washed and lysed in sample buffer (SDS 0.30% w/v, DTT 3.09% w/v, Tris -HCl 0.44% w/v, Tris base 0.27% w/v) and spent media were also collected. Embryo lysates and media thus collected from 4-5 separate experiments, as shown in Table 4 , were further analysed for the measurement of the TCA-precipitable 35 S according to the procedure described by Nieder et al. (1987) in order to estimate the protein synthesis and release by morulae and blastocysts in vitro with or without TNFa.
Ultrastructure of monkey and mouse embryos
Preimplantation embryos appearing normal under light microcope from both groups of monkeys (groups 1 and 2) and both groups of mice (groups I and II) were fixed in 3% glutaraldehyde in 0.1 mol/l phosphate buffer (pH 7.2), post-fixed in osmium tetroxide followed by dehydration in graded ethanol, and finally embedded in Spurr's resin. Semithin (0.5 mm) and thin (70 -80 nm) sections were cut and examined as described previously .
Statistical analysis
Comparisons between groups for different parameters were performed using the Fisher's exact probability test, Student's t-test and analysis of variance followed by multiple comparison test as applicable (Zar 1999) . Values are shown as means^S.D.
Results
Developmental status of monkey preimplantation stage embryo on day 6 after ovulation following early luteal phase (day 2 after ovulation) administration of mifepristone As shown in Table 1 , the rate of embryo recovery from mifepristone-treated monkeys (47%) was less than that from the control group (60%), however, this difference was not statistically significant. Analysis of developmental (4) 2.0^0.4 6.7^0.9 TNFa, 0.5 ng/ml (5) 1.5^0.6 3.6^0.8 (msm0.5), (msm5.0) P , 0.05 compared with control morula spent medium after treatment with 0.5 ng/ml, and 5.0 ng/ml, respectively.
[msm50] P , 0.01 compared with control morula spent medium after treatment with 50.0 ng/ml. status revealed that 57% (four/seven) of recovered embryos from the mifepristone-treated monkeys (group 2) were morulae and 29% (two/seven) embryos were desynchronized or degenerated. On the other hand, 67% (four/ six) of recovered embryos from the control group (group 1) of monkeys were blastocysts, while one out of six (17%) embryos was degenerated. However, these differences were not statistically significant.
Ultrastructural characteristics of monkey preimplantation stage embryos
Among six embryos recovered from group 1 (vehicle only) control treatment animals, one transitional stage embryo and four zonal blastocysts were analyzed for transmission electron microscopic study, while seven preimplantation stage embryos were recovered from monkeys subjected to early luteal phase mifepristone treatment, of which four morulae and one zonal blastocyst were further processed for ultrastructural examination. Figure 1 shows some cardinal ultrastructural features in these embryos obtained from control and mifepristone-treated groups of animals.
As shown in Fig. 1A , the blastomeres in transitional stage embryos from control animals had large nuclei with generally dispersed heterochromatin and round to ovoid shaped mitochondria with dense matrices and without any clear cristae, they were present in clusters along with lipid droplets, while focal areas of cytoplasm lacked any organelles. Distinct inter-blastomere spaces were infrequently present and contained cellular debris. Zonal blastocysts recovered from control animals (group 1) had an enlarged cavity, which was often irregular in shape. Trophoblast cells in embryos collected from control animals exhibited marked polarity with numerous microvilli on an apical surface (Fig. 1B -E) . Embryonal trophoblast cells overlying inner cell mass (ICM) cells were flattened and squamous in shape, while underlying cells of ICM showed numerous polyribosomes and coated caveolae and cytoplasmic vesicles were seen on free surfaces of blastomeres ( Fig. 1B and C) . Mitochondria were either elongated or large ovoid-shaped with discernible lamellar cristae with adjoining short strands of rough endoplasmic reticulum (Fig. 1C-F) . Nuclei of ICM blastomeres were large with dispersed heterochromatin, intra-nuclear annulate lamellae, and prominent nuclear pores (Fig. 1B) . Trophoblast cells showed long bundles of cytoplasmic filaments, distinctive apical junctions, infoldings of lateral cell membranes and desmosomes, rough endoplasmic reticulum (RER), occasional cisternae of RER filled with amorphous material, numerous plasma membrane-associated coated caveolae, cytoplasmic vesicles, and numerous microvilli on apical cell surfaces ( Fig. 1E and F) .
Morulae recovered from mifepristone-treated animals during the early luteal phase showed large intercellular spaces; a minimum degree of apposition of lateral cell membranes of blastomeres which, however, had retained their rounded cell shape with few apical microvilli; poorly developed junctional complexes and relatively small, pleiomorphic mitochondria, which were present in clusters (Fig. 1G) . As shown in Figs 1H and I, blastomeres of the single blastocyst retrieved following mifepristone exposure lacked the typical features generally found in such differentiated cells. For example, junctional complexes, though present, were not as well developed or as extensive as observed in blastocysts collected from control animals; mitochondria remained undifferentiated, large, and often showed a high degree of vacuolation, endoplasmic reticulum were poorly developed (Fig. 1I) . Furthermore, conspicuous absence of intra-cytoplasmic filaments was a marked feature of trophoblast cells in the single blastocyst obtained from mifepristone-exposed animals. Additionally, few morphological features, generally not seen in blastocysts from control animals, were found in blastomeres of the blastocyst recovered from mifepristonetreated monkeys. These included binucleate cells, large inter-blastomere spaces suggestive of lack of compaction, intra-cytoplasmic vacuoles, autolysosomes, lipofuscin, erythrophagolysosomes, myelinoid and multivesicular bodies. Large intra-cytoplasmic vacuoles containing cellular debris, as well as various cytoplasmic contents, lysosomes, multivesicular bodies, myelinoid bodies and fatty inclusion were also frequently seen in these blastomeres ( Fig. 1J and K) .
TNFa synthesis and secretion by monkey endometrial samples
There was a significant (P , 0.01) increase in the per cent area occupied by immunoprecipitation of TNFa in glandular (group 1, 7.4^1.0; group 2, 50.3^6.0) and vascular (group 1, 11.3^2.2; group 2, 44.8^4.3) compartments but not in stroma (group 1, 11.5^0.6; group 2, 14.6^1.1) on day 6 following mifepristone treatment compared with control group samples in histometric analysis of per cent area of immunoprecipitation (Fig. 2) .
Analysis of optical density data from dot blot and western blot experiments also revealed that the level of TNFa in homogenate (0.67^0.07) and spent media (1.62^0.03) was higher (P , 0.01) for endometrial samples collected from mifepristone-treated animals compared with that in homogenate (0.28^0.04) and spent medium (0.46^0.03) obtained from control animals. As shown in Fig. 3 , western blot analysis revealed two bands (17 and 35 kD) in spent media from both groups. Since both bands are absent in antibody-preincubated negative control samples, we presume that the two bands in endometrial secretion arose from monomeric and dimeric TNFa presentation. Although we did not further investigate this issue, similar observation has been reported earlier (Ameloot et al. 2001) .
The uterine fluid concentration of TNFa was significantly (P , 0.01) higher in mifepristone-treated animals (4.4^0.5 ng/100 mg protein) compared with control animals (1.2^0.3 ng/100 mg protein).
TNF-RI in the preimplantation stage monkey embryo
As shown in Fig. 4 , TNF-RI was localized in both inner cell mass and polar trophoblast cells in monkey blastocysts. Tables 2 and 3 show the details of developmental characteristics of morulae and blastocysts collected on day 4 of gestation and cultured for 24 h in vitro in the presence of different concentrations of TNFa.
Developmental status of mouse preimplantation stage embryos following TNFa exposure in vitro
As shown in Table 2 , at morula stage TNFa, at a concentration of 0.5 ng/ml (Group Ib), resulted in a marginally higher (P , 0.05) incidence of degeneration, while there was no significant change in the per cent morulae developed into blastocysts compared with controls (Group Ia). The number of embryos showing degenerated and arrested features, however, increased following exposure to higher concentrations (5 and 50 ng/ml) of TNFa, as compared Figure 1 Ultrastructural characteristics of blastomeres of embryos from control (group 1) monkeys (A-F) and from mifepristone-treated (group 2) monkeys (G-K). Arrow, junctional complex; Brackets, myelinoid bodies; c, caveolae; cd, cellular debris; Et, embryonal trophoblast; f, filaments; ICM, inner cell mass; l, lipid droplet; ly, lysosome; m, mitochondria; mb, multivesicular body; mv, microvilli; N, nucleus; rer, rough endoplasmic reticulum; ZP, zona pellucida. Bars: 2 mm (C, D); 3 mm (F, H -K); 5 mm (E); 6 mm (G); 10 mm (A, B).
with group Ia (control) and group Ib (TNF-a, 0.5 ng/ml). As a result, the per cent of morulae undergoing blastocyst development in group Ic (TNF-a, 5 ng/ml) and group Id (TNFa, 50 ng/ml) was significantly (P , 0.001) less than that found in group Ia (control) and group Ib (TNFa, 0.5 ng/ml).
As shown in Table 3 , when blastocysts were incubated with different doses of TNFa, a dose dependent increase (P , 0.01 for group IIb, and P , 0.001 for groups IIc and IId) in the per cent of embryos showing obvious degeneration, and a dose dependent decrease (P , 0.05 for group IIb, and P , 0.001 for groups IIc and IId) in the development of embryos to form expanded blastocysts as compared with those in control group embryos (group IIa) were recorded. No statistically significant change was observed in the per cent of blastocysts degenerated or expanded between group IIb (TNFa, 0.5 ng/ml) and group IIc (TNFa, 5 ng/ml). Also, no change was observed in the per cent blastocysts expanded between group IIc (TNFa, 5 ng/ml) and group IId (TNFa, 50 ng/ml). However, the per cent of blastocysts degenerated was higher in group IId as compared with group IIb (P , 0.01) and group IIc (P , 0.05). On the other hand, there was no change in the per cent number of blastocysts hatched following exposure to 0, 0.5, and 5.0 ng/ml TNFa in culture medium; however it decreased significantly (P , 0.01) with exposure to very high concentrations of TNFa (50 ng/ml) as compared with all other treatment groups.
Ultrastructural characteristics of mouse preimplantation stage embryos following TNFa exposure in vitro
Morulae and blastocysts collected on day 4 from mated female mice, without apparent abnormality as seen under stereozoom microscope were subjected to in vitro culture in medium containing different doses of TNFa (0, 0.5, 5 and 50 ng/ml) for 24 h following which apparently normal looking blastocysts were fixed for transmission electron microscope (TEM) examination. Figure 5 highlights the ultrastructural features of blastocysts developed from morulae and blastocysts, respectively, after 24 h culture with or without TNFa. TEM examination revealed that morulae that did develop into blastocysts in vitro, however, showed a higher degree of degenerative features in blastomeres following exposure to TNFa, especially at higher concentrations (5 ng/ml and 50 ng/ml) studied (Fig. 5C and D) compared with control embryos (Fig. 5A and B) . All blastocysts in this group (control and TNFa-exposed) were in either substage one or two of their development with clear blastocoelic cavities according to the classification described earlier (Nadijcka & Hillman 1974) . Ultrastructural examination of blastocysts from the control group revealed close clustering of mitochondria which were beginning to show cristae, but matrix remained mostly electron-dense; mitochondria were found closely associated with short strands of RER and small to large cisternae of RER were often engorged with amorphous inclusions; lipid droplets were occasionally lined with discrete glycogen particles. A large nucleus bearing 'honeycomb' nucleoli and evenly dispersed chromatin was characteristically observed. Distinctive apical and basolateral junctional complexes were discernible in such control group blastocysts (Fig. 5A and B) . Following exposure to TNFa, morulae developed into blastocysts but several degenerative features were clearly distinguishable: embryonic trophoblast showed loss of polarized features with apical as well as basolaterally distributed microvilli in cells; these cells were largely cuboidal and irregular in shape and showed a high degree of fatty inclusions, reactive lysosomes, lipofuscin, degenerative vacuoles, intracytoplasmic villi, blastomeres showing large intercellular spaces, woolly transformation of mitochondria and marked distortion in nuclear membrane contour more predominantly in blastomeres of the inner cell mass (Fig. 5C  and D) . These features were commonly not seen in the control group blastocysts.
Blastocysts incubated for 24 h in control medium underwent development to substage three type differentiation with ICM showing epiblast and proximal entoderm layer ( Fig. 5E and F) . Mitochondrial differentiation was found to be distinctive at this stage of development; polarization of cytoplasmic organelles characterized by distribution of mitochondria and Golgi zones in peri-nuclear location was seen (Fig. 5E and F) . Blastocysts exposed to TNFa at varying doses showed various degrees of cellular degenerative features (Fig. 5G-J) which included large intra-cytoplasmic vacuoles enclosing cellular debris, lipid droplets, lipofuscin containing large residual bodies, large conglomerations of glycogen, primitive types of myelinoid structures reminiscent of such bodies found in monkey blastocysts recovered from mifepristone-exposed animals ( Fig. 1J and K) , loss of mitochondrial differentiation and numerous primitive junctional complexes unlike blastocysts from the control group. Although stereological analysis was not done in the present study, the relative abundance of such degenerative features on subjective analysis was considered fewer in blastomeres of blastocysts exposed to TNFa compared with that found in morulae exposed to TNFa.
Protein synthesis in mouse preimplantation stage embryos following TNFa exposure in vitro Table 4 shows the data of 35 S-methionine labeled proteins in spent media as well as in lysates of morulae (group I) and blastocysts (group II) with and without TNFa (0.5, 5.0, and 50.0 ng/ml) treatment in vitro. It is evident from the data that embryonic protein synthesis as well as protein secretion were higher (P , 0.05) at blastocyst stage compared with morula stage between respective sets of different treatments (for example between control-treated morulae and blastocysts, 0.5 ng TNFa/ml treated morula and blastocysts, 5.0 ng TNFa/ml treated morula and blastocysts, and 50 ng TNFa/ml-treated morula and blstocysts) and that exposure to 5.0 and 50.0 ng TNFa per ml medium resulted in statistically significant (P , 0.05) inhibition of embryonic protein synthesis both at morula and blastocyst stages, while protein secretion by morula stage and blastocyst stage embryos was significantly (P , 0.01) affected even at 0.5 ng TNFa per ml medium.
Discussion
The results of the present study confirm that subcutaneous administration of mifepristone at a dose of 2 mg per kg body weight adversely affects the growth of preimplantation stage embryos, particularly from morula stage onwards (Ghosh et al. 1997 and that mouse preimplantation stage embryos exposed to TNFa in vitro exhibited failure of morula-to-blastocyst transition in a dose-dependent manner. Furthermore, ultrastructural examination revealed that mouse embryos exposed in vitro to TNFa showed many similarities in their ultrastructural features to blastomeres of embryos exposed in vivo to mifepristone with loss of trophoblast cell polarity, lack of mitochondrial maturity and a higher abundance of degenerative features. The degenerative features like the high degree of fatty inclusion, lipofuscin, myelin bodies and inter-blastomere spaces as observed in the blastomeres of embryos retrieved from mifepristone-exposed monkeys and in the blastomeres of mouse embryos exposed in vitro to TNFa are reminiscent of the reported ultrastructural characteristics of blastomeres of t 12 /t 12 and tw 32 /tw 32 mouse embryos (Hillman et al. 1970 /tw 32 embryos show delay in the process of morula-to-blastocyst transition (Hillman et al. 1970 , and lose their viability at very early stages of gestation (Nadijcka & Hillman 1975) . We have earlier reported that monkey embryos exposed in vivo to mifepristone fail to yield evolutive implantation (Ghosh et al. 1997) . Psychoyos & Prapas (1987) observed that administration of mifepristone to rats on days 1 and 2 of pregnancy resulted in a blockade of the morula-to-blastocyst transition.
The possibility that TNFa could be an effector candidate in mediating the embryotoxic effect of mifepristone is further substantiated by the fact that: (i) endometrial synthesis and secretion of TNFa is increased resulting in its higher concentration in luminal milieu following early luteal phase mifepristone treatment, and (ii) preimplantation blastocyst stage monkey embryos exhibit the receptor for TNFa (TNF-RI).
Although it is possible that mifepristone may directly act on preimplantation stage embryos, indirect evidence that: (i) mifepristone does not affect the growth of preimplantation stage embryos of the rhesus monkey (Wolf et al. 1990) , and (ii) there was no detectable mifepristone in the Figure 5 Ultrastructural characteristics of mouse blastocysts developed in vitro following 24 h culture of morulae in control medium (A, B) and in medium containing 0.5 ng/ml (C) and 50 ng/ml (D) TNFa. Ultrastructural features of mouse blastocysts grown for 24 h in control medium (E, F) and in medium containing 0.5 ng/ml (G), 5.0 ng/ml (H, I) and 50 ng/ml (J) TNFa. Arrow, junctional complex; asterix, intracytoplasmic vacuole; brackets, myelinoid bodies; cd, cellular debris; cv, intracytoplasmic vacuole; Ep, central epiblast; Et, embryonal trophoblast; g, glycogen; gl, perinuclear Golgi zone; l, lipid droplet; lp, lipofuscin; Lt, elongated lateral trophoblast; ly, lysosome; m, mitochondria; mb, multivesicular body; mo, vacuolated mitochondria; mw, woolly mitochondria; mv, microvilli; N, nucleus; Pent, proximal entoderm; rer, rough endoplasmic reticulum; ZP, zona pellucida. Note that the inset area in (E) is shown in enlarged form in (F). Bars: 2 mm (F); 3 mm (B, I, J); 4 mm (C); 6 mm (G,H); 10 mm (A, E); 15 mm (D).
luminal fluid following luteal phase administration of mifepristone (2 mg/kg body weight) to rhesus monkeys (unpublished data), casts serious doubt on this possibility. We have demonstrated earlier that low dose mifepristone applied during the early luteal phase does not affect the serum concentrations of estradiol-17b and progesterone and thereby ovarian functions in the rhesus monkey (Ghosh & Sengupta 1993) . It now appears likely that early luteal phase antiprogestin action affects endometrial function in a way that the luminal environment becomes hostile and cannot support preimplantation embryo growth (Antonakis et al. 1994 , Beir-Hellwig et al. 1994 , Ding et al. 1994 , Psychoyos et al. 1995 , Qui et al. 2001 ). This notion is indeed substantiated by the observation that passive immunization against progesterone in the mother during early pregnancy resulted in arrested embryonic growth in mice, rats and ferrets (Wang et al. 1984 , Rider & Heap 1986 , Phillips et al. 1988 .
Mifepristone is a potent anti-glucocorticoid and antiprogesterone (Philibert, 1984) . Generally, mifepristonemediated inhibition of glucocorticoid activity in mammalian tissues, as well as inhibition of progesterone action specifically in endometrial cells, tend to increase TNFa (Gaillard et al. 1985 , Busso et al. 1987 , Lazar et al. 1992 . In an interesting study, Laird et al. (1996) have demonstrated that there was a down regulation of TNFa production by secretory phase endometrium in the presence of progesterone in vitro. Therefore, we anticipated that early luteal phase application of mifepristone blocks progesterone and glucocorticoid action in the implantation stage endometrium and upregulates endometrial synthesis and secretion of TNFa. The results of the present study have now indeed demonstrated that mifepristone administration on day 2 after ovulation results in increased endometrial synthesis and secretion of TNFa on day 6 after ovulation.
In the next phase, we tested the hypothesis that a high level of luminal TNFa affects embryo growth. Because of practical and ethical constraints this hypothesis could not be tested using monkey embryos, and therefore it was tested using mouse embryos. TNFa affects morula-toblastocyst transition and blastocyst growth in vitro in a dose-dependent manner. Morphological changes, based on ultrastructural examination, and functional changes, based on the profile of proteins synthesized and released by apparently normal-looking embryos exposed to TNFa in vitro, were significantly different compared with those found in embryos in control treatment. The possibility that TNFa present in culture medium can adversely affect the growth of the preimplantation stage embryo is also substantiated by several reports based on studies using different models. TNFa has been shown in vivo and in vitro to reduce the viability of mouse blastocysts, and rat blastocysts along with high levels of apoptotic cell death (Pampfer et al. 1994a ,b, Wuu et al. 1999 , Kurzawa et al. 2001 . The observation in the present study that preimplantation stage embryos express receptors for TNFa corroborates well with earlier studies on mouse preimplantation stage embryos (Pampfer et al. 1994b (Pampfer et al. , 1995 .
Morula-to-blastocyst transition is a critical step in the process of embryogenesis characterized by ultrastructural polarization (Enders et al. 1990 , Ducibella et al. 1995 , Ohsugi et al. 1999 and specific profiles of proteins synthesized at this developmental stage (Zheng et al. 1993 , Shi et al. 1994 , Sasaki et al. 1999 . Mouse blastocysts allowed to develop in vivo are classified into four substages based on their ultrastructural features: substage one, when blastoceolic cavity is well formed but not expanded, substage two, when the cavity is expanded but ICM cells do not show any clear-cut differentiation, substage three, when ICM shows differentiation into epiblast and proximal entoderm, and substage four, when visceral entoderm develops and forms a continuous layer around the blastocyst cavity (Nadijcka & Hillman 1974) . Embryos in the control group showed development until substage three, which was not achieved by embryos exposed to TNFa. It is interesting to note that in the present study, though a population of morulae underwent differentiation into blastocysts, their development was significantly compromised after TNFa exposure in vitro, characterized by a loss of cell polarity in trophoblast cells, lack of mitochondrial maturity, and a higher occurrence of inter-blastomere space, intra-cytoplasmic vacuoles, lysosomes and lipofuscin and multivesicular bodies (Ghadially 1988 ). It appears that input from the immediate microenvironment can influence these processes (Neider et al. 1987 , Enders et al. 1989 . A subgroup of embryos both in mice and monkeys had escaped the adverse effects putatively mediated by TNFa. In the present study, one out of seven embryos could attain blastocyst stage, and in our previous reports one out of twelve embryos, and five out of sixteen embryos could attain blastocyst stage despite application of mifepristone to rhesus monkeys (Ghosh et al. 1997 . In mice, more than 20% of morulae could develop into blastocysts and a similar percentage of blastocysts could expand and hatch even in the presence of TNFa, despite a dose-dependent increase in the number of degenerated embryos. It has been shown in mouse that the morphological event of cavitation at the morula stage can occur even when either DNA replication was inhibited (Dean & Rossant 1984) or cytokinesis was blocked (Pratt et al. 1981) . It is also possible that these embryos do not express the functional receptors for TNFa or the proteins required for their down-stream signal transduction (Takahashi et al. 1995 , Sridhar et al. 2001 . The significance of this observation is only speculative at this point in time. It may be conjectured that the group of embryos, which are relatively resistant to TNFa, may escape environmental hostility and thereby give an advantage of providing effort toward establishing pregnancy despite the possibility that such environmental hostility may cause some defect in the organism. Alternatively, based on experiments using TNFa positive and TNFa knock-out mice, Toder et al. (2003) concluded that TNFa boosts death signaling to kill the embryo if initial damages triggered by detrimental stimuli culminate in structural anomalies and stimulate protective mechanisms if the repair of these damages may prevent maldevelopment.
It is to be noted that morulae which could develop in mifepristone-treated female monkeys, and in the presence of TNFa in mouse embryo cultures, exhibited a higher abundance of ultrastructural defects in their blastomeres along with a deficit in protein synthesis. Despite the fact that some events in embryogenesis may proceed in a fixed action pattern even in a hostile environment, environmental deficit or hostility can leave an unfavourable imprint, which in turn may adversely affect the required sufficiency and time synchrony of interactions between the embryo and endometrium resulting in failure of blastocyst implantation. This notion is supported by the observation that apparently normal-looking preimplantation stage embryos retrieved from luteal phase mifepristone-treated monkeys could not support implantation and evolutive pregnancy (Ghosh et al. 1997) , and that apparently normal-looking mouse blastocysts exposed to TNFa in vitro failed to implant (Wuu et al. 1999) .
Thus, we conclude that delay in embryo development along with the onset of degenerative changes observed in monkey preimplantation stage embryos following mifepristone exposure may be contributed by increased TNFa concentrations in uterine luminal fluid. The possibility that early luteal phase mifperistone administration can affect the equilibrium of a larger network of cytokines in the endometrium, involving transforming growth factor b (TGFb), interferon g (IFNg) and interleukins (ILs), besides TNFa (Antanakis et al. 1994 , Rotello et al. 1991 , Shaarawy & Nagui 1997 resulting in irreversible damage to the preimplantation embryo needs to be examined. Additionally, the relative depletion of specific growth factors like epidermal growth factor (EGF) and insulin like growth factors (IGFs) in the endometrium may also potentiate detrimental effect of TNFa (Wu et al. 1996 , Ho et al. 1999 on embryo growth following luteal phase administration of mifepristone.
